levodopa has been researched along with oxotremorine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, K | 1 |
| Finn, BW; Mendez, JS | 1 |
| Lippmann, W; Pugsley, TA | 2 |
| Eshel, Y; Korczyn, AD | 1 |
| Coward, DM; Doggett, NS; Sayers, AC | 1 |
| Lippman, W; Pugsley, TA | 1 |
| Fujiwara, M; Inoue, K; Ueki, S | 1 |
| Lippmann, W; Pugsley, T | 1 |
| Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
| Cotzias, GC; Tang, LC | 1 |
| Lucas, TS; Quock, RM | 2 |
| De Cock, E; Elseviers, M; Tourwé, D; Van Binst, G; Van Marsenille, M; Vander Elst, P | 1 |
| Claesen, M; Dumont, P; Garzon-Aburbeh, A; Poupaert, JH | 1 |
| Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
| Boismare, F; Chadelaud, M; Chretien, P; Daoust, M; Moore, N; Saligaut, C | 1 |
| Cotzias, GC; Dunn, M; Tang, LC | 1 |
| Bartholini, G; Bigler, R; Brossi, A; Burns, JJ; Kaiser, A; Pletscher, A; Pool, W; Sheppard, H | 1 |
| Sillén, U | 1 |
| Hjälmås, K; Rubenson, A; Sillén, U | 1 |
21 other study(ies) available for levodopa and oxotremorine
| Article | Year |
|---|---|
Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Brain; Brocresine; Chlorpromazine; Cold Temperature; Ditiocarb; Droxidopa; Fenclonine; Levodopa; Male; Methyltyrosines; Oxotremorine; Rats; Thyroid Gland | 1976 |
Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats.
Topics: Animals; Apomorphine; Brain; Brain Chemistry; Carbidopa; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Levodopa; Male; Movement; Nerve Degeneration; Neurons; Neurotransmitter Agents; Oxotremorine; Parkinson Disease, Secondary; Rats; Rotation; Stereotaxic Techniques; Substantia Nigra; Synaptic Transmission; Time Factors | 1975 |
Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Biogenic Amines; Brain; Drug Interactions; Indoles; Levodopa; Male; Medulla Oblongata; Mice; Myocardium; Norepinephrine; Oxazines; Oxotremorine; p-Hydroxyamphetamine; Rats; Reflex; Reserpine; Serotonin | 1977 |
1-[2-Amino-1-[1-(naphthyloxy)methyl] ethyl] piperidine hydrochloride: specific inhibition of brain serotonin uptake and related activities.
Topics: 5-Hydroxytryptophan; Amides; Animals; Brain; Catecholamines; Cerebral Cortex; Drug Interactions; Fenfluramine; In Vitro Techniques; Levodopa; Male; Mice; Myocardium; Oxotremorine; p-Chloroamphetamine; Piperidines; Rats; Serotonin; Synaptosomes | 1977 |
Abolition of oxotremorine effects by L-DOPA pretreatment.
Topics: Animals; Catalepsy; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Humans; Levodopa; Male; Mice; Oxotremorine; Tears; Tremor | 1979 |
The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent.
Topics: Analgesics; Animals; Cats; Decerebrate State; Dogs; Drug Interactions; Drug Tolerance; Female; Levodopa; Male; Mice; Oxotremorine; Rabbits; Rats; Species Specificity; Spinal Cord; Time Factors; Tremor; Urea | 1977 |
Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
Topics: Amitriptyline; Animals; Apomorphine; Biogenic Amines; Brain; Desipramine; Drug Synergism; Gastric Juice; Imipramine; In Vitro Techniques; Levodopa; Mice; Morpholines; Myocardium; Norepinephrine; Oxotremorine; Pupil; Rats; Reflex; Reserpine; Serotonin; Tyramine; Viloxazine | 1976 |
[Behavioral pharmacology of a new antidepressant, lopramine].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1976 |
Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Brain; Drug Synergism; Indenes; Indoles; Levodopa; Male; Mice; Norepinephrine; Oxotremorine; Rats; Reflex; Reserpine; Serotonin; Tyramine | 1976 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Modification of the actions of some neuroactive drugs by growth hormone.
Topics: Animals; Apomorphine; Behavior, Animal; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Growth Hormone; Levodopa; Male; Mice; Oxotremorine; Parkinson Disease; Psychotropic Drugs; Tyrosine | 1976 |
A selective potentiation by naloxone of L-dopa but not atropine suppression of oxotremorine-induced tremor in mice.
Topics: Animals; Atropine; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Time Factors; Tremor | 1985 |
Synthesis and conformational study of two L-prolyl-L-leucyl-glycinamide analogues with a reduced peptide bond.
Topics: Animals; Dipeptides; Drug Synergism; Indicators and Reagents; Levodopa; Magnetic Resonance Spectroscopy; MSH Release-Inhibiting Hormone; Oxidation-Reduction; Oxotremorine; Protein Conformation; Rats; Structure-Activity Relationship | 1986 |
A lymphotropic prodrug of L-dopa: synthesis, pharmacological properties, and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)prop anoyl] propane-1,2,3-triol.
Topics: Administration, Oral; Animals; Brain; Dopamine; Haplorhini; Hydrolysis; Kinetics; Levodopa; Lymph; Male; Mice; Oxotremorine; Phenylpropionates; Rats; Reserpine; Time Factors | 1986 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Topics: Administration, Oral; Animals; Choline; Cytidine Diphosphate Choline; Diarrhea; Female; Hypothermia; Levodopa; Mice; Oxotremorine; Salivation; Syndrome; Tremor | 1985 |
Changing the actions of neuroactive drugs by changing brain protein synthesis.
Topics: Adenosine Triphosphate; Animals; Apomorphine; Behavior, Animal; Brain; Caudate Nucleus; Chloramphenicol; Cyclic AMP; Cycloheximide; Depression, Chemical; Dopamine; Levodopa; Mice; Motor Activity; Nerve Tissue Proteins; Oxotremorine; Poly I-C; Puromycin; Receptors, Adrenergic; Receptors, Cholinergic; Stimulation, Chemical | 1974 |
L-DOPA: chemical modifications and biological evaluation.
Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermia; Levodopa; Male; Mice; Oxotremorine; Parkinson Disease; Reserpine; Structure-Activity Relationship; Tremor | 1974 |
Central neurotransmitter mechanisms involved in the control of urinary bladder function. An experimental study in the rat.
Topics: Animals; Brain; Diazepam; Levodopa; Male; Models, Biological; Muscimol; N-Methylscopolamine; Neurotransmitter Agents; Oxotremorine; Rats; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA-A; Receptors, Muscarinic; Scopolamine Derivatives; Urinary Bladder | 1980 |
Potentiation by naloxone of the anti-oxotremorine effect of L-DOPA.
Topics: Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Tremor | 1983 |
Central cholinergic mechanisms in L-DOPA induced hyperactive urinary bladder of the rat.
Topics: Animals; Atropine; Brain; Calcium; Hexamethonium Compounds; Levodopa; Male; N-Methylscopolamine; Oxotremorine; Phentolamine; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Reserpine; Scopolamine Derivatives; Sotalol; Urinary Bladder | 1982 |